Export
Model List of Essential Medicines
clear
Found 35 recommendations for 17 medicines and 12 therapeutic equivalents
Removed medicines and rejected applications are not shown. Show them.
-
Apixaban General information
SectionMedicines affecting coagulationIndicationsTherapeutic equivalent to dabigatran for Venous thromboembolism Therapeutic equivalent to dabigatran for Other specified atrial fibrillation -
Dabigatran General information
SectionMedicines affecting coagulation- Oral > Solid: 110 mg; 150 mg
-
Dalteparin General information
SectionMedicines affecting coagulationIndicationsTherapeutic equivalent to enoxaparin for Acute ischaemic heart disease Therapeutic equivalent to enoxaparin for Venous thromboembolism -
Darbepoetin alfa General information
SectionAntianaemia medicinesIndicationsTherapeutic equivalent to erythropoiesis-stimulating agents for Anaemia due to chronic disease -
Deferasirox General information
SectionOther medicines for haemoglobinopathies- Oral > Solid > dispersible tablet: 100 mg; 125 mg; 250 mg; 400 mg; 500 mg
- Oral > Solid > tablet: 90 mg; 180 mg; 360 mg
IndicationsOther specified sickle cell disorders or other haemoglobinopathies Thalassaemias Therapeutic equivalent to deferoxamine for Thalassaemias -
Deferiprone General information
SectionOther medicines for haemoglobinopathiesIndicationsTherapeutic equivalent to deferasirox for Other specified sickle cell disorders or other haemoglobinopathies Therapeutic equivalent to deferasirox for Thalassaemias -
Deferoxamine General information
SectionOther medicines for haemoglobinopathies- Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate)
-
Desmopressin General information
SectionMedicines affecting coagulation- Parenteral > General injections > IV: 4 µg per mL in 1 mL ampoule (acetate)
- Local > Nasal > Spray: 10 µg per dose (acetate)
Indications -
Edoxaban General information
SectionMedicines affecting coagulationIndicationsTherapeutic equivalent to dabigatran for Venous thromboembolism Therapeutic equivalent to dabigatran for Other specified atrial fibrillation -
Enoxaparin General information
SectionMedicines affecting coagulation- Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule; 120 mg per 0.8 mL in ampoule
Indications -
Epoetin alfa General information
SectionAntianaemia medicinesIndicationsTherapeutic equivalent to erythropoiesis-stimulating agents for Anaemia due to chronic disease -
Epoetin beta General information
SectionAntianaemia medicinesIndicationsTherapeutic equivalent to erythropoiesis-stimulating agents for Anaemia due to chronic disease -
Epoetin theta General information
SectionAntianaemia medicinesIndicationsTherapeutic equivalent to erythropoiesis-stimulating agents for Anaemia due to chronic disease -
Erythropoiesis-stimulating agents General information
SectionAntianaemia medicines- Parenteral > General injections > unspecified: 1000 IU per 0.5 mL pre-filled syringe; 2000 IU per 0.5 mL pre-filled syringe; 3000 IU per 0.3 mL pre-filled syringe; 4000 IU per 0.4 mL pre-filled syringe; 5000 IU per 0.5 mL pre-filled syringe; 6000 IU per 0.6 mL pre-filled syringe; 8000 IU per 0.8 mL pre-filled syringe; 10000 IU per 1 mL pre-filled syringe; 20000 IU per 0.5 mL pre-filled syringe; 40000 IU per 1 mL pre-filled syringe
Indications -
Ferrous salt General information
SectionAntianaemia medicines- Oral > Liquid: 25 mg per mL iron (as sulfate)
- Oral > Solid: 60 mg iron
Indications -
Ferrous salt + folic acid General information
SectionAntianaemia medicines- Oral > Solid > tablet: 60 mg elemental iron + 400 µg tablet; 60 mg elemental iron + 2.8 mg
-
Folic acid General information
SectionAntianaemia medicines- Oral > Solid: 1 mg tablet; 5 mg tablet
- Oral > Solid: 400 µg
-
Heparin sodium General information
SectionMedicines affecting coagulation- Parenteral > General injections > IV: 1000 IU per mL in 5 mL ampoule; 20000 IU per mL in 5 mL ampoule; 5000 IU per mL in 5 mL ampoule
-
Hydroxocobalamin General information
SectionAntianaemia medicines- Parenteral > General injections > IM: 1 mg per mL in 1 mL ampoule (as acetate); 1 mg per mL in 1 mL ampoule (as hydrochloride); 1 mg per mL in 1 mL ampoule (as sulfate)
-
Hydroxycarbamide (hydroxyurea) General information
SectionOther medicines for haemoglobinopathies- Oral > Solid > dosage form: 200 mg; 500 mg; 1 g; 100 mg
-
Methoxy polyethylene glycol-epoetin beta General information
SectionAntianaemia medicinesIndicationsTherapeutic equivalent to erythropoiesis-stimulating agents for Anaemia due to chronic disease -
Nadroparin General information
SectionMedicines affecting coagulationIndicationsTherapeutic equivalent to enoxaparin for Acute ischaemic heart disease Therapeutic equivalent to enoxaparin for Venous thromboembolism -
Phytomenadione General information
SectionMedicines affecting coagulation- Parenteral > General injections > IV: 10 mg per mL in ampoule; 1 mg per mL in ampoule
- Oral > Solid: 10 mg tablet
-
Protamine sulfate General information
SectionMedicines affecting coagulation- Parenteral > General injections > IV: 10 mg per mL in 5 mL ampoule
-
Rivaroxaban General information
SectionMedicines affecting coagulationIndicationsTherapeutic equivalent to dabigatran for Venous thromboembolism Therapeutic equivalent to dabigatran for Other specified atrial fibrillation -
Tranexamic acid General information
SectionMedicines affecting coagulation- Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule
Indications -
Warfarin General information
SectionMedicines affecting coagulation- Oral > Solid: 5 mg (sodium salt); 1 mg (sodium salt); 2 mg (sodium salt); 0.5 mg (sodium salt)